Danaher (DHR) Suffers a Larger Drop Than the General Market: Key Insights
https://www.zacks.com/stock/news/2207860/danaher-dhr-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2207860
Jan 09, 2024 - Danaher (DHR) concluded the recent trading session at $230.87, signifying a -1.7% move from its prior day's close.
0
Reasons to Retain Danaher (DHR) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2200076/reasons-to-retain-danaher-dhr-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2200076
Dec 19, 2023 - Strength in the Life Sciences segment and accretive acquisition bode well for Danaher (DHR). The company's measures to reward its shareholders are encouraging.
0
Danaher (DHR) Stock Falls Amid Market Uptick: What Investors Need to Know
https://www.zacks.com/stock/news/2199662/danaher-dhr-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2199662
Dec 18, 2023 - Danaher (DHR) closed the most recent trading day at $226.45, moving -0.34% from the previous trading session.
0
Danaher (DHR) Acquires Abcam to Boost Life Sciences Segment
https://www.zacks.com/stock/news/2194747/danaher-dhr-acquires-abcam-to-boost-life-sciences-segment?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2194747
Dec 07, 2023 - Danaher (DHR) acquires Abcam for $5.7 billion, thus adding to its Life Sciences portfolio. This move will facilitate the mapping of complex diseases and expedite the drug discovery process.
0
Danaher (DHR) Declines More Than Market: Some Information for Investors
https://www.zacks.com/stock/news/2193860/danaher-dhr-declines-more-than-market-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2193860
Dec 05, 2023 - The latest trading day saw Danaher (DHR) settling at $219.44, representing a -1.21% change from its previous close.
0